ArticleNeuropsychopharmacology reports2026
Electroconvulsive Therapy for Severe Refractory Tardive Dystonia Without Active Depression: A Case Report.
Article in Neuropsychopharmacology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTardive dystonia is a disabling tardive syndrome associated with exposure to dopamine receptor-blocking agents. Responses to pharmacotherapy are often limited, and evidence supporting electroconvulsive therapy (ECT) remains sparse. CASE PRESENTATION: A woman in her early 60s with recurrent major depressive disorder (in full remission at presentation) developed progressive cervical-truncal dystonia with tremor-like involuntary movements after years of fluctuating psychotropic regimens that included exposure to antipsychotic medication. Neurologic evaluation, including brain magnetic resonance imaging and electroencephalography, was unremarkable, and no structural, metabolic, or neurodegenerative cause was identified from available records. Multiple pharmacologic strategies-including anticholinergics, benzodiazepines, and valbenazine-provided insufficient control, and she became wheelchair-dependent. During a recent psychiatric admission, she received ECT primarily for refractory tardive dystonia. Severity was tracked using the Abnormal Involuntary Movement Scale (AIMS), which was 27 at admission and 25 immediately before ECT. After benzodiazepines were discontinued, she underwent an acute course of bitemporal ECT over approximately 6 weeks under propofol (50 mg) and succinylcholine (50 mg) anesthesia, with a recorded stimulus charge of 100 mC and pulse width of 1.0 ms. Seizure duration on electroencephalography ranged from 25 to 85 s (motor 25-59 s when recorded), and the device/local-record postictal suppression index was 1-2. Motor symptoms improved progressively; by the middle of the course, she no longer required a wheelchair and ambulated independently. The AIMS score decreased to 14 later in the course and remained 14 at completion of the acute course. However, dystonia gradually recurred after ECT discontinuation.
conclusionECT may provide clinically meaningful short-term improvement in severe refractory tardive dystonia even in the absence of active depressive symptoms; relapse after acute treatment may occur, and continuation strategies may be required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.